This inventor holds 2 USPTO granted patents. Top assignee: Kyoto Pharmaceutical Industries, Ltd.. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kyoto, JP (2001)
- Nagaokakyo, JP (2001)
Company Filing History:
Years Active: 2001
Title: Mamoru Kanda: Innovator in Medicinal Chemistry
Introduction
Mamoru Kanda is a distinguished inventor based in Kyoto, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of therapeutic agents for allergic conditions. With a total of 2 patents to his name, Kanda's work has the potential to impact the lives of many individuals suffering from allergies.
Latest Patents
Kanda's latest patents include innovative formulations that utilize cromoglycic acid compounds. The first patent focuses on the medicinal use of these compounds, specifically detailing the cromoglycic acid compound of the formula (I). The second patent presents a therapeutic agent for allergic dermatitis, which is designed to treat allergic reactions caused by type IV allergies. This agent contains diethyl L-lysylcromoglycate, showcasing Kanda's commitment to addressing pressing health issues.
Career Highlights
Kanda is currently affiliated with Kyoto Pharmaceutical Industries, Ltd., where he continues to advance his research and development efforts. His work at this esteemed company has allowed him to collaborate with other talented professionals in the field, further enhancing the impact of his inventions.
Collaborations
Kanda has worked alongside notable colleagues such as Hiroaki Shirahase and Akihisa Yoshimi. Their collaborative efforts have contributed to the successful development of innovative therapeutic solutions.
Conclusion
Mamoru Kanda's contributions to medicinal chemistry exemplify the importance of innovation in addressing health challenges. His patents reflect a dedication to improving the quality of life for individuals with allergies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile